Browse studies

Find your next paid study

1 recruiting study matching your filters

An Open-Label, Single-Dose Clinical Study to Evaluate the Pharmacokinetics of Nemtabrutinib in Participants With Severe Renal Impairment

The purpose of this study is to learn what happens to nemtabrutinib in a person's body when given to participants with severe kidney disease and to healthy par…

Severe Renal ImpairmentHealthy

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT07734610